scispace - formally typeset
G

Giuseppina Bonizzi

Researcher at European Institute of Oncology

Publications -  43
Citations -  6245

Giuseppina Bonizzi is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 16, co-authored 27 publications receiving 5771 citations. Previous affiliations of Giuseppina Bonizzi include University of California, Berkeley & University of California, San Diego.

Papers
More filters
Journal ArticleDOI

The two NF-κB activation pathways and their role in innate and adaptive immunity

TL;DR: Results strongly suggest that the classical and alternative pathways to NF-κB activation have distinct regulatory functions, one that is mostly involved in innate immunity and the other in adaptive immunity.
Journal ArticleDOI

Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway

TL;DR: It is shown that IKKα is required for B cell maturation, formation of secondary lymphoid organs, increased expression of certain NF-κB target genes, and processing of the NF-σκB2 (p100) precursor.
Journal ArticleDOI

The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells

TL;DR: It is demonstrated that p53 regulates polarity of cell division in mammary SCs and suggested that loss of p53 favors symmetric divisions of cancer SCs, contributing to tumor growth.
Journal ArticleDOI

IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development

TL;DR: IKKα is a critical intermediate in a pathway that controls mammary epithelial proliferation in response to RANK signaling via cyclin D1 through NF-κB activation.
Journal ArticleDOI

Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers

TL;DR: The basis for the IKKα dependence of the induction of these genes in response to engagement of the lymphotoxin β receptor is investigated and a novel type of NF‐κB‐binding site is identified that is preferentially recognized by RelB:p52 dimers.